Automated diagnosis of mild cognitive impairment and depression in older adults
The Proactive Screening and diagnosis of mild cognitive impairment and depression in patients aged 65 and over: An Implementation Study
This study is working on a new tool to help doctors better diagnose mild cognitive impairment and late-life depression in people aged 65 and older, using both mobile apps and traditional tests to make sure everyone gets the best care possible.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Miro Health INC NIH-funded |
| Lab location | 1 site (Sacramento, UNITED STATES) |
| Project ID | NIH-10706563 on NIH RePORTER |
What this research studies
This research focuses on developing an automated platform for diagnosing mild cognitive impairment (MCI) and late-life depression in individuals aged 65 and over. By utilizing mobile assessments and traditional evaluations, the study aims to refine machine learning algorithms that analyze data collected from real-world settings. Participants will engage in both novel and conventional assessments to help improve the accuracy of diagnoses and enhance patient care. The ultimate goal is to create a universally accessible tool that can assist in early detection and management of these conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults aged 65 and over who may be experiencing symptoms of mild cognitive impairment or depression.
Not a fit: Patients who are younger than 65 or do not exhibit symptoms of cognitive impairment or depression may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate diagnoses of cognitive impairment and depression, improving treatment outcomes for older adults.
How similar studies have performed: Other research has shown promise in using technology for diagnosing cognitive impairments, indicating that this approach could be effective.
Where this research is happening
Sacramento, UNITED STATES
- Miro Health INC — Sacramento, United States (Active)
Researchers
- Principal investigator: Glenn, Shenly — Miro Health INC
- Study coordinator: Glenn, Shenly
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.